[go: up one dir, main page]

KR900004323A - 유화 조성물 - Google Patents

유화 조성물 Download PDF

Info

Publication number
KR900004323A
KR900004323A KR1019890013930A KR890013930A KR900004323A KR 900004323 A KR900004323 A KR 900004323A KR 1019890013930 A KR1019890013930 A KR 1019890013930A KR 890013930 A KR890013930 A KR 890013930A KR 900004323 A KR900004323 A KR 900004323A
Authority
KR
South Korea
Prior art keywords
water
emulsifying composition
glycerin
ratio
weight ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019890013930A
Other languages
English (en)
Inventor
히데오 나카지마
미유키 고치
사토시 도모마사
Original Assignee
후쿠하라 요시하루
가부시키가이샤 시세이도
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 후쿠하라 요시하루, 가부시키가이샤 시세이도 filed Critical 후쿠하라 요시하루
Publication of KR900004323A publication Critical patent/KR900004323A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/734—Fullerenes, i.e. graphene-based structures, such as nanohorns, nanococoons, nanoscrolls or fullerene-like structures, e.g. WS2 or MoS2 chalcogenide nanotubes, planar C3N4, etc.
    • Y10S977/735—Carbon buckyball
    • Y10S977/737—Carbon buckyball having a modified surface
    • Y10S977/738—Modified with biological, organic, or hydrocarbon material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/788—Of specified organic or carbon-based composition
    • Y10S977/797—Lipid particle
    • Y10S977/798—Lipid particle having internalized material
    • Y10S977/799—Containing biological material
    • Y10S977/801—Drug
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/84—Manufacture, treatment, or detection of nanostructure
    • Y10S977/895—Manufacture, treatment, or detection of nanostructure having step or means utilizing chemical property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

내용 없음

Description

유화 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 C성분으로서 인지질을 사용한 경우의 입자 지름과 (A)/(C)비의 관계를 나타내는 설명도이다.
제2도는 C성분으로서 인지질과 비이온성 계면활성물질을 사용한 경우의 입자 지름과 (A)/(B)비의 관계를 나타내는 설명도이다.
제3도는 글리세린 농도와 입자 지름의 관계를 나타내는 설명도이다.

Claims (2)

  1. (A) 지용성 약제 및 지질, (B) 글리세린 및 물 및 (C) 인지질 및/또는 분자량이 1000 이상인 수용성 비이온성 계면활성물질을 적어도 함유하며, (A)/(C)=0.5 내지 5(중량비)임을 특징으로 하는, 평균 입자 지름이 0.010 내지 0.070㎛인 유화조성물.
  2. 제1항에 있어서, 유화시의 글리세린과 물의 비(중량비)가 3 : 7 내지 9 : 1임을 특징으로 하는 유화조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890013930A 1988-09-29 1989-09-28 유화 조성물 Ceased KR900004323A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP63-245120 1988-09-29
JP24512088 1988-09-29

Publications (1)

Publication Number Publication Date
KR900004323A true KR900004323A (ko) 1990-04-12

Family

ID=17128920

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890013930A Ceased KR900004323A (ko) 1988-09-29 1989-09-28 유화 조성물

Country Status (6)

Country Link
US (1) US5338761A (ko)
EP (1) EP0361928B1 (ko)
KR (1) KR900004323A (ko)
CA (1) CA1337397C (ko)
DE (1) DE68914929T2 (ko)
ES (1) ES2052016T3 (ko)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
US7081445B2 (en) * 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
AU614465B2 (en) * 1989-04-05 1991-08-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
US5364632A (en) * 1989-04-05 1994-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
CA2056445A1 (en) * 1989-05-26 1990-11-27 Ho-Wah Hui Injectable clarithromycin composition
JP2785981B2 (ja) * 1989-11-20 1998-08-13 株式会社資生堂 乳化組成物
TW211015B (ko) * 1990-01-11 1993-08-11 Nippon Shinyaku Co Ltd
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
DE4200728A1 (de) * 1992-01-14 1993-07-15 Basf Ag Stabile, fluessige praeparate fettloeslicher substanzen
SG45449A1 (en) 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
US5637317A (en) * 1992-05-18 1997-06-10 Dietl; Hans Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing same
DE59310166D1 (de) * 1992-05-18 2001-05-31 Ciclomulsion Ag Cyclosporin(e) enthaltende pharmazeutische Zubereitung zur intravenösen Applikation sowie Verfahren zu ihrer Herstellung
PT589843E (pt) 1992-09-25 2002-04-29 Novartis Ag Composicoes farmaceuticas contendo ciclosporinas
DE4338086A1 (de) * 1993-11-08 1995-05-11 Dietl Hans Cyclosporin(e) enthaltende pharmazeutische Zubereitung zur oralen Applikation sowie Verfahren zu ihrer Herstellung
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
US20020099067A1 (en) * 1993-07-08 2002-07-25 Ulrich Posanski Pharmaceutical compositions for sparingly soluble therapeutic agents
DE4338046A1 (de) * 1993-11-08 1995-05-11 Dietl Hans Fettlösliche Arzneimittel erhaltende flüssige pharmazeutische Zubereitung zur oralen Anwendung
DE59510233D1 (de) 1994-11-03 2002-07-11 Novartis Ag Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
US5603951A (en) * 1994-11-09 1997-02-18 Hanmi Pharm. Ind. Co., Ltd. Cyclosporin-containing soft capsule compositions
DE4440337A1 (de) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
KR0167613B1 (ko) * 1994-12-28 1999-01-15 한스 루돌프 하우스, 니콜 케르커 사이클로스포린-함유 연질캅셀제 조성물
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
DE19549852B4 (de) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
US5660858A (en) * 1996-04-03 1997-08-26 Research Triangle Pharmaceuticals Cyclosporin emulsions
WO1998018492A1 (en) * 1996-10-25 1998-05-07 Yoshitomi Pharmaceutical Industries Ltd. Method of inhibiting drug precipitation
DE69826272T2 (de) 1997-01-30 2005-11-17 Novartis Ag Ölfreie pharmazeutische zusammensetzung welche cyclosporin enthält
US6413489B1 (en) * 1997-04-15 2002-07-02 Massachusetts Institute Of Technology Synthesis of nanometer-sized particles by reverse micelle mediated techniques
US6281175B1 (en) 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
US6054421A (en) * 1997-09-23 2000-04-25 Scimed Life Systems, Inc. Medical emulsion lubricant
IL122084A (en) * 1997-10-31 1999-09-22 Lurident Ltd Formulation for personal care with mucoadhesive properties
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
TWI241915B (en) * 1998-05-11 2005-10-21 Ciba Sc Holding Ag A method of preparing a pharmaceutical end formulation using a nanodispersion
DE19825856A1 (de) * 1998-06-10 1999-12-16 Labtec Gmbh Topische Arzneimittelzubereitung
KR100777647B1 (ko) 1998-08-19 2007-11-19 스키에파마 캐나다 인코포레이티드 프로포폴의 수용성 주사용 분산액
AU6283299A (en) * 1998-10-01 2000-04-17 Elan Pharma International Limited Controlled release nanoparticulate compositions
US8236352B2 (en) 1998-10-01 2012-08-07 Alkermes Pharma Ireland Limited Glipizide compositions
US20040013613A1 (en) * 2001-05-18 2004-01-22 Jain Rajeev A Rapidly disintegrating solid oral dosage form
US8293277B2 (en) * 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
US7521068B2 (en) * 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
US6428814B1 (en) * 1999-10-08 2002-08-06 Elan Pharma International Ltd. Bioadhesive nanoparticulate compositions having cationic surface stabilizers
US6447806B1 (en) 1999-02-25 2002-09-10 Novartis Ag Pharmaceutical compositions comprised of stabilized peptide particles
IL138616A0 (en) * 2000-09-21 2001-10-31 J P M E D Ltd Oil in glycerin emulsion
US7393548B2 (en) 1999-03-22 2008-07-01 J.P. M.E.D. Ltd. Nano oil in glycerin emulsion
DE19961733A1 (de) * 1999-12-21 2001-06-28 Ciclomulsion Ag Cyclosporin(e) enthaltende hypertone pharmazeutische Zubereitung zur Anwendung bei neurologischen Erkrankungen und als Neuroprotektivum sowie Verfahren zu ihrer Herstellung
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US6861060B1 (en) * 2000-04-21 2005-03-01 Elena Luriya Personal care formulations
US20040156872A1 (en) * 2000-05-18 2004-08-12 Elan Pharma International Ltd. Novel nimesulide compositions
US7198795B2 (en) 2000-09-21 2007-04-03 Elan Pharma International Ltd. In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
US20040101566A1 (en) * 2002-02-04 2004-05-27 Elan Pharma International Limited Novel benzoyl peroxide compositions
US20040258757A1 (en) * 2002-07-16 2004-12-23 Elan Pharma International, Ltd. Liquid dosage compositions of stable nanoparticulate active agents
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US6979672B2 (en) * 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
EP2016833A1 (de) * 2007-07-17 2009-01-21 Cognis IP Management GmbH Emulsion
MX340897B (es) 2007-10-02 2016-07-29 Theranos Inc Dispositivos modulares de punto de cuidado y usos de los mismos.
US10294376B2 (en) * 2008-11-12 2019-05-21 Archer Daniels Midland Company Lecithin and plasticizer compositions and methods
US8772358B2 (en) * 2008-11-12 2014-07-08 Archer Daniels Midland Co. Lecithin and plasticizer compositions and methods
US9186324B2 (en) * 2010-02-07 2015-11-17 J.P.M.E.D. Ltd. Hair follicle targeting compositions
EA201791738A1 (ru) 2012-05-09 2018-03-30 Вестерн Юниверсити Оф Хелт Сайенсиз Пролипосомальные композиции тестостерона
US20140275261A1 (en) 2013-03-15 2014-09-18 Dr. Reddy's Laboratories, Inc. Diclofenac parenteral compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5562010A (en) * 1978-10-31 1980-05-10 Ajinomoto Co Inc Fat emulsion for intravenous injection
JPS6030652B2 (ja) * 1979-05-07 1985-07-17 株式会社ミドリ十字 静脈注射用脂肪乳剤
US4677099A (en) * 1981-09-04 1987-06-30 Yeda Research And Development Co., Ltd. Medical processes employing a novel lipid fraction
JPH0647533B2 (ja) * 1984-08-10 1994-06-22 裕 水島 ４−ビフエニリル酢酸系化合物含有脂肪乳剤
IL78929A0 (en) * 1985-07-29 1986-09-30 Abbott Lab Microemulsion compositions for parenteral administration
US4816247A (en) * 1985-09-11 1989-03-28 American Cyanamid Company Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs
US4784845A (en) * 1985-09-16 1988-11-15 American Cyanamid Company Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs
DE3623376A1 (de) * 1986-07-11 1988-01-21 Behringwerke Ag Pharmazeutische formulierung und verfahren zu deren herstellung
JPS6348214A (ja) * 1986-08-18 1988-02-29 Morishita Seiyaku Kk １−〔２−（２，４−ジクロロフエニル）−３−メチル−１−ペンテニル〕−１ｈ−イミダゾ−ルを含有する水中油型脂肪乳剤
US4835002A (en) * 1987-07-10 1989-05-30 Wolf Peter A Microemulsions of oil in water and alcohol
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers

Also Published As

Publication number Publication date
ES2052016T3 (es) 1994-07-01
US5338761A (en) 1994-08-16
EP0361928A2 (en) 1990-04-04
DE68914929D1 (de) 1994-06-01
EP0361928B1 (en) 1994-04-27
DE68914929T2 (de) 1994-08-11
CA1337397C (en) 1995-10-24
EP0361928A3 (en) 1991-06-05

Similar Documents

Publication Publication Date Title
KR900004323A (ko) 유화 조성물
CA2194226A1 (en) Stable Oil-In-Water Emulsions Incorporating a Taxine (Taxol) and Method of Making Same
ATE246486T1 (de) Zubereitungen vom emulsionstyp w/o mit erhöhtem wassergehalt, enthaltend ferner ein oder mehrere alkylmethiconcopolyole und/oder alkyl- dimethiconcopolyole sowie kationische polymere
KR890700018A (ko) 화장료
ES2173123T3 (es) Composiciones de emulsion de tensioactivo viscoso.
HK1043936A1 (zh) 含有脂调节剂的新的配方
DE50108380D1 (de) Hautbehandlungsmittel
ATE118177T1 (de) Emulsion.
KR870002835A (ko) 이온화성 소수성약제의 약제학적 제조방법
ES2025064B3 (es) Mezclas preservadoras.
ATE176151T1 (de) Körper waschmittel
SE8903061D0 (sv) Emulsionsbraensle innehaallande mycket tjock olja
DK0399843T5 (da) Adjuvans-formulering i form af en submikron oliedråbeemulsion
BR8701461A (pt) Policarbodiimida tensao-ativa,emulsao,composicao reticulavel,processos de preparacao das mesmas,processo de reticulacao de resina e produto
KR870002834A (ko) 유제조성물의 제조방법
FR2804015B1 (fr) Nanoemulsion contenant des lipides amphiphiles et un polymere non ionique et utilisations
FR2811565B1 (fr) Emulsion eau-dans-huile et ses utilisations notamment dans le domaine cosmetique
ES2034188T3 (es) Composiciones cosmeticas.
BR9917259A (pt) Microemulsão transparente
KR960703162A (ko) 비이온성 계면활성제의 안정한 수성 유액(Stable aqueous emulsions of nonionic surfactants)
DE59209873D1 (de) Stabile multiple emulsionen
DE59407568D1 (de) Fliessfähiges emulsionskonzentrat
FR2548676B1 (fr) Compositions de biopolymeres et leur procede de preparation
FR2796308B1 (fr) Composition sous forme d'emulsion eau-dans-huile et ses utilisations cosmetiques
KR920014422A (ko) 크리임상 조성물의 제법

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19890928

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19940927

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19890928

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19971021

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19980123

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19971021

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I